We’ve engineered amplitude-modulated frequencies with harmonic RF sidebands to disrupt abnormal and cancerous cells. It delivers real-time analog sweeps for bioelectric disruption of diseased tissue with high signal fidelity and MHz-range precision targeting, DAC-controlled firmware, RF modulation circuitry, and biological validation using resonance modeling to confirm selective cellular effects.